孤立性远端深静脉血栓形成后血栓后综合征汇总发生率的系统评价与Meta分析
本系统评价与Meta分析遵循PRISMA指南并注册方案(CRD42021282136),检索截至2021年12月的前瞻性研究,汇总孤立性远端深静脉血栓形成后血栓后综合征的发生率。结果显示汇总发生率为17%(95%CI 11-26%),异质性高(I²=89%),随访时长与发生率无关(p=.71),严重表现(含溃疡)风险约为五十分之一,作者认为亟需随机试验支持预防干预。
要点
- 孤立性远端深静脉血栓形成后血栓后综合征汇总发生率为17%(95%CI 11-26%)。
- 血栓后综合征严重表现(含溃疡)风险约为五十分之一。
- 研究间存在显著临床、方法学和统计学异质性,汇总研究存在较大偏倚风险。
核心结论
- 孤立性远端深静脉血栓形成后血栓后综合征风险约为五分之一,严重临床表现(包括溃疡)风险约为五十分之一。
- 研究间存在显著的临床、方法学和统计学异质性,汇总研究存在较大的偏倚风险。
- 亟需随机试验以支持预防血栓后综合征的干预措施。
研究设计与样本
- 系统评价与Meta分析,遵循PRISMA指南并使用注册方案(CRD42021282136)。
- 检索MEDLINE、Embase、Cochrane对照试验注册库、Clinicaltrials.gov、欧盟临床试验、国际标准随机对照试验编号以及澳大利亚和新西兰试验注册库,检索截至2021年12月。
- 纳入报告血栓后综合征发生情况的前瞻性研究并进行汇总分析。
主要发现
- 血栓后综合征汇总发生率为17%(95%CI 11-26%)(7项研究,217例事件,1105名参与者)。
- 异质性高(I²=89%)。
- Meta回归显示血栓后综合征发生率与随访时长无关(p=.71)。
- 3项研究(302名参与者)报告了血栓后综合征严重程度:78%为轻度(Villalta评分5-9),11%为中度(Villalta评分10-14),11%为重度(Villalta评分≥15)。
局限性
- 研究间存在显著的临床、方法学和统计学异质性。
- 汇总研究存在较大的偏倚风险。
- 异质性高(I²=89%)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To identify the rate of post-thrombotic syndrome (PTS) after isolated distal deep venous thrombosis (IDDVT) by performing a meta-analysis of the rate of PTS across randomised and observational studies. DATA SOURCES: MEDLINE, Embase, the Cochrane Controlled Trials Register, Clinicaltrials.gov, European Union Clinical Trials, International Standard Randomised Controlled Trial Number, and the Australian and New-Zealand Trials Registries. REVIEW METHODS: This review followed PRISMA guidelines using a registered protocol (CRD42021282136). Databases were searched up to December 2021 and prospective studies reporting the development of post-thrombotic syndrome were included; these were pooled with the meta-analysis. RESULTS: The results showed a post-thrombotic rate of 17% (95% CI 11 - 26%) (seven studies, 217 cases, 1 105 participants). Heterogeneity was high (I2 = 89%). On meta-regression, the rate of post-thrombotic syndrome was not correlated with the length of follow up (p = .71). Three studies (302 participants) reported the severity of post-thrombotic syndrome: 78% were mild (Villalta score 5 - 9); 11% were moderate (Villalta score 10 - 14), and 11% were severe (Villalta score ≥ 15). CONCLUSION: The risk of post-thrombotic syndrome after IDDVT was one in five and the risk of severe clinical manifestations, including ulceration, was one in 50. There was significant clinical, methodological, and statistical heterogeneity between studies and a substantial risk of bias from pooled studies. Randomised trials to support interventions for prevention of post-thrombotic syndrome are urgently needed.
引用
- Turner BRH, Thapar A, Jasionowska S, et al. Systematic Review and Meta-Analysis of the Pooled Rate of Post-Thrombotic Syndrome After Isolated Distal Deep Venous Thrombosis. Eur J Vasc Endovasc Surg. 2022. PMID: 36257568. doi:10.1016/j.ejvs.2022.10.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。